Skip to Content
Merck
  • Identification of biomarkers in the hair of dogs: new diagnostic possibilities in the study and control of visceral leishmaniasis.

Identification of biomarkers in the hair of dogs: new diagnostic possibilities in the study and control of visceral leishmaniasis.

Analytical and bioanalytical chemistry (2014-08-31)
Jairo Torres Magalhães-Junior, Paulo Roberto Ribeiro Mesquita, Wyllian Franz dos Santos Oliveira, Fábio Santos Oliveira, Carlos Roberto Franke, Frederico de Medeiros Rodrigues, Jailson Bittencourt de Andrade, Stella Maria Barrouin-Melo
ABSTRACT

Visceral leishmaniasis (VL) is a zoonosis whose etiologic agent in the Americas is Leishmania infantum, and dogs are the main host. Research and innovation in diagnostic techniques are essential to improve the surveillance and control of VL in endemic areas. The present study investigates the profile of the volatile organic compounds (VOCs) emitted by healthy dogs and by dogs infected by L. infantum to detect variations in the VOCs that may be used as biomarkers in the diagnosis of VL. In total, 36 dogs were selected from an endemic area and divided into three groups: G1, not infected with L. infantum; G2, infected without clinical signs of VL; and G3, infected with clinical signs of VL. To analyze the profiles of the VOCs emitted by dogs from the three groups, solid-phase microextraction (SPME) combined with gas chromatography-mass spectrometry (GC-MS) was used. Variations were observed between the profiles of the VOCs emitted in the three groups studied, and they also differentiated infected animals with or without clinical signs. Six VOCs were identified as potential biomarkers of infection, with significant variations between healthy dogs (G1) and infected dogs (G2 + G3). The detection of variations between groups G2 and G3 suggested that the profiles of some VOCs may be related to the type of immune response and the parasite load of the infected dogs. This study demonstrated the possibility of analysis of VOCs as biomarkers of VL in diagnostic, clinical, and epidemiological work.

MATERIALS
Product Number
Brand
Product Description

Benzaldehyde, European Pharmacopoeia (EP) Reference Standard
Supelco
Octanal, analytical standard
Sigma-Aldrich
Benzaldehyde, ≥98%, FG, FCC
Sigma-Aldrich
Octanal, ≥95%, FCC, FG
Sigma-Aldrich
Octanal, 99%
Sigma-Aldrich
Heptanal, ≥95%, FCC, FG
Sigma-Aldrich
Benzaldehyde, ReagentPlus®, ≥99%
Sigma-Aldrich
Octanal, natural, ≥95%, FCC, FG
Supelco
Benzaldehyde, analytical standard
Sigma-Aldrich
Benzaldehyde, puriss. p.a., ≥99.0% (GC)
Sigma-Aldrich
Benzaldehyde, purified by redistillation, ≥99.5%
Sigma-Aldrich
Benzaldehyde, natural, FCC, FG
Supelco
Benzaldehyde, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Heptaldehyde, 95%
Supelco
Heptaldehyde, analytical standard
Supelco
Nonanal, analytical standard
Sigma-Aldrich
Decanal, FCC, FG
Sigma-Aldrich
Decanal, natural, ≥97%, FG
Sigma-Aldrich
Nonanal, 95%
Sigma-Aldrich
Nonanal, ≥95%, FCC
Sigma-Aldrich
Decanal, ≥98% (GC), liquid
Supelco
Decanal, analytical standard
Sigma-Aldrich
Nonanal, natural, ≥98%, FG